Apr-24-24 09:00AM
|
|
Apr-23-24 11:53AM
|
|
08:53AM
|
|
08:40AM
|
|
08:36AM
|
|
07:30AM |
Loading… |
07:30AM
|
|
Apr-16-24 04:01PM
|
|
Apr-02-24 07:30AM
|
|
Mar-01-24 09:55AM
|
|
Feb-29-24 11:33PM
|
|
12:00PM
|
|
09:21AM
|
|
Feb-28-24 08:50AM
|
|
08:40AM
|
|
07:52AM
|
|
07:30AM |
Loading… |
07:30AM
|
|
Feb-21-24 04:01PM
|
|
Feb-12-24 09:55AM
|
|
08:50AM
|
|
Jan-23-24 09:55AM
|
|
08:50AM
|
|
Jan-09-24 08:46AM
|
|
Jan-04-24 07:30AM
|
|
Jan-02-24 04:01PM
|
|
Dec-23-23 09:00AM
|
|
Dec-15-23 02:30PM
|
|
Nov-24-23 02:05PM
|
|
Nov-20-23 09:55AM
|
|
Nov-09-23 10:01PM
|
|
Nov-01-23 08:27AM
|
|
10:48PM |
Loading… |
Oct-31-23 10:48PM
|
(Thomson Reuters StreetEvents) |
08:50AM
|
|
07:30AM
|
|
Oct-24-23 04:01PM
|
|
Oct-20-23 12:08PM
|
|
Sep-29-23 12:43PM
|
|
Aug-27-23 08:40AM
|
|
Aug-22-23 08:14AM
|
|
Aug-18-23 09:04PM
|
|
Aug-10-23 10:33PM
|
|
Aug-07-23 06:14AM
|
|
Jul-25-23 10:05PM
|
(Thomson Reuters StreetEvents) +30.39% |
01:06PM
|
|
08:45AM
|
|
07:30AM
|
|
Jul-24-23 08:31AM
|
|
Jul-18-23 04:01PM
|
|
Jul-17-23 08:00AM
|
|
Jul-04-23 08:24PM
|
|
Jun-06-23 04:01PM
|
|
May-03-23 06:14AM
|
|
May-02-23 08:45AM
|
|
07:30AM
|
|
May-01-23 04:01PM
|
|
Apr-09-23 09:21AM
|
|
Apr-05-23 01:40PM
|
|
Mar-31-23 09:35AM
|
|
Mar-30-23 02:20PM
|
|
Mar-29-23 10:13AM
|
|
Mar-27-23 12:04PM
|
|
Mar-23-23 02:25PM
|
|
Mar-03-23 06:57PM
|
|
Feb-28-23 11:25AM
|
|
08:00AM
|
|
Feb-27-23 04:01PM
|
|
11:47AM
|
|
Feb-23-23 10:50AM
|
|
Jan-25-23 02:52AM
|
|
Jan-21-23 04:51PM
|
|
Jan-09-23 08:00AM
|
|
Jan-03-23 04:01PM
|
|
Nov-30-22 04:01PM
|
|
Nov-23-22 04:01PM
|
|
Nov-10-22 09:40AM
|
|
Nov-07-22 09:55AM
|
|
08:50AM
|
|
Nov-01-22 09:15AM
|
|
08:00AM
|
|
Oct-31-22 04:01PM
|
|
Oct-24-22 09:40AM
|
|
Oct-05-22 08:50AM
|
|
Sep-21-22 12:00PM
|
|
Sep-20-22 10:30AM
|
|
Sep-12-22 08:30AM
|
|
Aug-22-22 09:55AM
|
|
Aug-05-22 09:55AM
|
|
Aug-04-22 09:09AM
|
|
Aug-03-22 04:01PM
|
|
09:40AM
|
|
08:45AM
|
|
08:30AM
|
(Thomson Reuters StreetEvents) |
07:30AM
|
|
07:29AM
|
|
Aug-02-22 04:01PM
|
|
Jul-22-22 12:00PM
|
|
Jun-22-22 09:14AM
|
|
Jun-19-22 09:49AM
|
|
May-05-22 06:52AM
|
|
May-03-22 09:15AM
|
|
May-02-22 04:01PM
|
|
|
|
|
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Patel Sanj K | CHAIRMAN & CEO | Mar 07 '24 | Sale | 21.02 | 65,012 | 1,366,552 | 0 | Mar 11 07:05 PM | Patel Sanj K | CHAIRMAN & CEO | Mar 06 '24 | Sale | 21.00 | 5,582 | 117,222 | 65,012 | Mar 06 05:37 PM | Patel Sanj K | CHAIRMAN & CEO | Mar 04 '24 | Sale | 21.49 | 12,742 | 273,834 | 70,594 | Mar 06 05:37 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 01 '24 | Option Exercise | 10.93 | 9,659 | 105,560 | 27,247 | Mar 01 06:26 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 01 '24 | Option Exercise | 1.86 | 18,844 | 35,050 | 62,736 | Mar 05 04:31 PM | Tessari Eben | CHIEF OPERATING OFFICER | Mar 01 '24 | Option Exercise | 1.59 | 656 | 1,043 | 124,036 | Mar 05 04:34 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 01 '24 | Sale | 21.77 | 18,844 | 410,234 | 44,892 | Mar 05 04:31 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 01 '24 | Sale | 21.45 | 9,659 | 207,186 | 17,588 | Mar 01 06:26 PM | Tessari Eben | CHIEF OPERATING OFFICER | Mar 01 '24 | Sale | 22.03 | 1,189 | 26,194 | 122,847 | Mar 05 04:34 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 28 '24 | Option Exercise | 8.83 | 5,126 | 45,263 | 22,714 | Mar 01 06:26 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 28 '24 | Sale | 21.79 | 5,126 | 111,696 | 17,588 | Mar 01 06:26 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27 '24 | Option Exercise | 1.86 | 10,156 | 18,890 | 55,048 | Feb 29 04:26 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27 '24 | Sale | 21.03 | 10,156 | 213,581 | 44,892 | Feb 29 04:26 PM | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03 '24 | Option Exercise | 8.83 | 12,000 | 105,960 | 27,632 | Jan 04 04:30 PM | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03 '24 | Sale | 20.00 | 12,000 | 240,000 | 15,632 | Jan 04 04:30 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 02 '24 | Option Exercise | 13.88 | 16,670 | 231,380 | 33,675 | Jan 04 04:30 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 02 '24 | Sale | 19.17 | 16,670 | 319,564 | 17,005 | Jan 04 04:30 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Dec 19 '23 | Option Exercise | 13.88 | 9,316 | 129,306 | 26,321 | Dec 21 04:26 PM | Megna Michael R | CHIEF ACCOUNTING OFFICER | Dec 19 '23 | Sale | 19.13 | 9,316 | 178,215 | 17,005 | Dec 21 04:26 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07 '23 | Option Exercise | 1.86 | 28,600 | 53,196 | 73,492 | Dec 11 04:20 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07 '23 | Sale | 17.65 | 28,600 | 504,758 | 44,892 | Dec 11 04:20 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05 '23 | Option Exercise | 1.86 | 400 | 744 | 45,292 | Sep 06 07:03 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05 '23 | Sale | 17.53 | 400 | 7,012 | 44,892 | Sep 06 07:03 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25 '23 | Option Exercise | 1.86 | 29,000 | 53,940 | 70,910 | Jul 27 04:30 PM | Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25 '23 | Sale | 19.14 | 29,000 | 555,160 | 41,910 | Jul 27 04:30 PM |
|